With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Regina Myers, MD||Young Investigator Grants||2019||Pennsylvania|
|Identification of Synthetically Immunogenic Compounds to Synergize with Immunotherapy In Neuroblastoma||Children's Hospital of Philadelphia / Adam Wolpaw, MD/PhD||Young Investigator Grants||2019||Pennsylvania|
|Single-cell Profiling of Early T-cell Precursor Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / David Teachey, MD||Single-cell Pediatric Cancer Atlas Grant||2019||Pennsylvania|
|Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors||University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD||Young Investigator Grants||2019||Ontario|
|Dissecting Pediatric Brain Tumour Progression Using Single-nuclei Sequencing||University Health Network / Trevor Pugh, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Ontario|
|Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion||Research Institute at Nationwide Children's Hospital / Dean Lee, MD/PhD||Reach Grants||2019||Ohio|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|
|Platform development for target identification in high risk pediatric leukemias||Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8 Initiative||2019||New York|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD & David T. Teachey, MD||Innovation Grants||2019||New York|
|Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas||New York University School of Medicine / Danny Reinberg, PhD||Reach Grants||2019||New York|